Akari Therapeutics Rally Continues As William Blair Upgrades

By: via Benzinga
William Blair upgraded shares of Akari Therapeutics PLC (ADR) (NASDAQ: AKTX), given the $73 billion enterprise value of Akari, which ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.